Media

Academic Research, Media Coverage and Press Releases

Media Coverage

Articles & Interviews

Blog
Bloomberg: IPOX® Founder Josef Schuster on the Growing Momentum Behind Industrial Spinoffs
Bloomberg: IPOX® Founder Josef Schuster on the Growing Momentum Behind Industrial Spinoffs
Reuters: IPOX® Vice President Kat Liu Comments on Navan’s Nasdaq Debut and AI-Driven IPO Market
Reuters: IPOX® Vice President Kat Liu Comments on Navan’s Nasdaq Debut and AI-Driven IPO Market
Reuters: IPOX® Analyst Muehlbauer Comments on Medline’s Blockbuster U.S. IPO Filing
Reuters: IPOX® Analyst Muehlbauer Comments on Medline’s Blockbuster U.S. IPO Filing
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Biotech IPO Market Amid MapLight’s Nasdaq Debut
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Biotech IPO Market Amid MapLight’s Nasdaq Debut
Q3 Earnings Season Kicks Off for IPOX® Index Constituents
Q3 Earnings Season Kicks Off for IPOX® Index Constituents
Reuters: IPOX® CEO Josef Schuster Discusses IPO Market Flexibility Amid U.S. Government Shutdown and Navan’s Planned Listing
Reuters: IPOX® CEO Josef Schuster Discusses IPO Market Flexibility Amid U.S. Government Shutdown and Navan’s Planned Listing
Reuters: IPOX® Analyst Lukas Muehlbauer on Biotech Firms Turning to Alternative IPO Paths During U.S. Government Shutdown
Reuters: IPOX® Analyst Lukas Muehlbauer on Biotech Firms Turning to Alternative IPO Paths During U.S. Government Shutdown
Reuters: IPOX® CEO Josef Schuster on Biotech Market Strength and MapLight Therapeutics’ IPO Timing
Reuters: IPOX® CEO Josef Schuster on Biotech Market Strength and MapLight Therapeutics’ IPO Timing
Reuters: IPOX® CEO Josef Schuster Comments on Cerebras’ Withdrawal from U.S. IPO Plans
Reuters: IPOX® CEO Josef Schuster Comments on Cerebras’ Withdrawal from U.S. IPO Plans
Reuters: IPOX® Analyst Lukas Muehlbauer on U.S. Government Shutdown’s Impact on IPO Market Momentum
Reuters: IPOX® Analyst Lukas Muehlbauer on U.S. Government Shutdown’s Impact on IPO Market Momentum
Reuters: IPOX® CEO Josef Schuster on Positive Sentiment for PE-Backed IPOs
Reuters: IPOX® CEO Josef Schuster on Positive Sentiment for PE-Backed IPOs
Reuters: IPOX® CEO Josef Schuster Comments on Wealthfront’s IPO Filing
Reuters: IPOX® CEO Josef Schuster Comments on Wealthfront’s IPO Filing
Reuters: IPOX® CEO Josef Schuster Comments on Alliance Laundry’s $4.3 Billion IPO Valuation
Reuters: IPOX® CEO Josef Schuster Comments on Alliance Laundry’s $4.3 Billion IPO Valuation
Reuters: IPOX® VP Kat Liu on on Beta Technologies’ IPO
Reuters: IPOX® VP Kat Liu on on Beta Technologies’ IPO
Reuters: IPOX® VP Kat Liu on Investor Outlook for Insurance IPOs
Reuters: IPOX® VP Kat Liu on Investor Outlook for Insurance IPOs
Bloomberg: IPO Revival Lifts First Trust US Equity Opportunities ETF
Bloomberg: IPO Revival Lifts First Trust US Equity Opportunities ETF
Bloomberg: IPOX® VP Kat Liu on Rockpoint IPO and Canadian Market Outlook
Bloomberg: IPOX® VP Kat Liu on Rockpoint IPO and Canadian Market Outlook
Reuters: IPOX® VP Kat Liu on Neptune Insurance’s IPO Prospects
Reuters: IPOX® VP Kat Liu on Neptune Insurance’s IPO Prospects
Reuters: IPOX® Research Associate Muehlbauer on Pattern Group’s Nasdaq Debut
Reuters: IPOX® Research Associate Muehlbauer on Pattern Group’s Nasdaq Debut
Bloomberg: IPOX® Analyst Muehlbauer on SMG’s Zurich Debut and Boost for European IPOs
Bloomberg: IPOX® Analyst Muehlbauer on SMG’s Zurich Debut and Boost for European IPOs
Barron’s: IPOX® CEO Josef Schuster on Navigating IPO Allocations and Timing
Barron’s: IPOX® CEO Josef Schuster on Navigating IPO Allocations and Timing
Bloomberg: IPOX® 100 U.S. Index Outperforms as IPO Market Momentum Builds
Bloomberg: IPOX® 100 U.S. Index Outperforms as IPO Market Momentum Builds
Reuters: IPOX® Vice President Liu on Netskope’s Strong Nasdaq Debut
Reuters: IPOX® Vice President Liu on Netskope’s Strong Nasdaq Debut
Bloomberg: IPOX® Founder Josef Schuster on Netskope IPO Amid AI-Driven Cybersecurity Demand
Bloomberg: IPOX® Founder Josef Schuster on Netskope IPO Amid AI-Driven Cybersecurity Demand
Reuters: IPOX®’s Kat Liu Comments on StubHub’s Volatile NYSE Debut
Reuters: IPOX®’s Kat Liu Comments on StubHub’s Volatile NYSE Debut
Nikkei: IPOX® Founder Josef Schuster talks about the “Golden Age of IPOs” in the US
Nikkei: IPOX® Founder Josef Schuster talks about the “Golden Age of IPOs” in the US
Reuters: IPOX® VP Kat Liu on Via’s $3.5 Billion NYSE Debut
Reuters: IPOX® VP Kat Liu on Via’s $3.5 Billion NYSE Debut
Reuters: IPOX® VP Kat Liu highlights Klarna’s brand power in $1.37B U.S. IPO
Reuters: IPOX® VP Kat Liu highlights Klarna’s brand power in $1.37B U.S. IPO
Morningstar: IPOX®-Linked ETF "FPX" Among Top Holders of GE Vernova Stock
Morningstar: IPOX®-Linked ETF "FPX" Among Top Holders of GE Vernova Stock
Reuters: IPOX® CEO Josef Schuster Expects Strong U.S. IPO Momentum Through 2026
Reuters: IPOX® CEO Josef Schuster Expects Strong U.S. IPO Momentum Through 2026

Videos

Blog
Josef Schuster on the IPOX ETFs (TD Ameritrade)
Josef Schuster on the IPOX ETFs (TD Ameritrade)
Josef Schuster on the Airbnb IPO (Yahoo Finance)
Josef Schuster on the Airbnb IPO (Yahoo Finance)
U.S. IPO market expected to see more unicorns: IPOX Schuster (BNN Bloomberg)
U.S. IPO market expected to see more unicorns: IPOX Schuster (BNN Bloomberg)
IPOs in the Global Capital Markets (LSE)
IPOs in the Global Capital Markets (LSE)
Japan Post Financial Units to Outperform, Schuster Says (Bloomberg TV)
Japan Post Financial Units to Outperform, Schuster Says (Bloomberg TV)
Josef Schuster talks about tech market trends (CGTN America)
Josef Schuster talks about tech market trends (CGTN America)
Josef Schuster weighs in on Alibaba (CGTN America)
Josef Schuster weighs in on Alibaba (CGTN America)

 Press Releases

Academic Research

Blog
FPX_Defensive_Growth_Jan_2023-1.jpg
IPOX® Research: Achieving real returns in stagflationary periods
The IPOX® SPAC Research - U.S. SPAC Market Review and Outlook Q1 2022
The IPOX® SPAC Research - U.S. SPAC Market Review and Outlook Q1 2022
The IPOX® SPAC Research – U.S. SPAC Market Review and Outlook, FY 2021
The IPOX® SPAC Research – U.S. SPAC Market Review and Outlook, FY 2021
Factor Exposures for the IPOX® Portfolio 2020
Factor Exposures for the IPOX® Portfolio 2020
Factor Exposures for the IPOX® Portfolio 2019
Factor Exposures for the IPOX® Portfolio 2019
Navigating the IPO Market with IPOX® IPO Indexes
Navigating the IPO Market with IPOX® IPO Indexes
The Cross-Section of European IPO Returns
The Cross-Section of European IPO Returns
The Case for Indexing Chinese IPOs
The Case for Indexing Chinese IPOs
IPOs: Insights from Seven European Countries
IPOs: Insights from Seven European Countries
Do IPO index portfolios improve the investment opportunities for mean–variance investors?
Do IPO index portfolios improve the investment opportunities for mean–variance investors?